Ribociclib and Cariprazine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Ribociclib
Cariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Ribociclib (Kisqali) can slow down the liver enzyme that clears cariprazine (Vraylar) from your body. When that enzyme is blocked, cariprazine and its active breakdown product build up higher than usual. In studies with a similar strong blocker, cariprazine levels roughly doubled.
Higher levels mean you could feel more of cariprazine's side effects, like restlessness, drowsiness, tremor, or trouble sitting still. The good news is this is very manageable. Your care team can lower your cariprazine dose or space it out further while you are on ribociclib. Please don't change either medicine on your own, just talk with your doctor or pharmacist so they can adjust things safely.
Mechanism: Ribociclib is a strong CYP3A4 inhibitor; cariprazine is a CYP3A4 substrate. Inhibition reduces clearance and increases exposure to cariprazine and its active metabolite didesmethylcariprazine. Neither is a prodrug requiring 3A4 activation, so effect is amplified, not reduced.
Magnitude: With ketoconazole, cariprazine AUC and Cmax rose ~100%. Evidence: probable. Onset: unspecified.
Management (per labeling for strong 3A4 inhibitors):
- Schizophrenia/bipolar mania, new start: 1.5 mg every 3 days, may increase to 1.5 mg every other day.
- Bipolar depression/adjunct MDD: 1.5 mg every 3 days.
- Stable 1.5 or 3 mg daily: reduce to 1.5 mg every 3 days; stable 4.5 or 6 mg daily: reduce to 1.5 mg every other day.
- On inhibitor discontinuation: dose may need upward adjustment.
Monitor for EPS, akathisia, and sedation.
What happens
Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine
Interaction Deep Dive
When cariprazine (a CYP3A4 substrate) is given together with a potent CYP3A4 inhibitor, the levels of cariprazine as well as its active metabolite, didesmethylcariprazine, may rise. In drug interaction trials, giving cariprazine alongside ketoconazole (a strong CYP3A4 inhibitor) produced an approximately 100% rise in both AUC and Cmax. For this reason, patients starting cariprazine for schizophrenia or bipolar mania while on a strong CYP3A4 inhibitor should begin at 1.5 mg orally every 3 days, with a possible increase to 1.5 mg orally every other day if warranted by clinical response and tolerability. In the case of bipolar depression or adjunctive treatment of MDD with concurrent use of a strong CYP3A4 inhibitor, the dose is 1.5 mg orally every 3 days. If a strong CYP3A4 inhibitor is being started in a patient already on a steady cariprazine regimen: for those currently receiving 1.5 or 3 mg once daily, the cariprazine dose should be modified to 1.5 mg orally every 3 days upon starting the strong inhibitor; for those currently on 4.5 or 6 mg once daily, the cariprazine dose should be adjusted to 1.5 mg orally every other day when the strong inhibitor is introduced. Once the strong CYP3A4 inhibitor is stopped, an increase in the cariprazine dose may be required, guided by clinical response and tolerability1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
This combination is manageable with dose adjustment and monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise.
- Your team will likely lower your cariprazine dose or space it further apart while you take ribociclib. For example, someone on a stable daily dose may be moved to a smaller dose taken every few days.
- They may watch you more closely for side effects like restlessness, drowsiness, or muscle stiffness.
- When ribociclib is stopped, your cariprazine dose may need to go back up.
Ask your pharmacist or prescriber to confirm the right cariprazine schedule for you, and report any new or worsening side effects.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In drug interaction studies, giving cariprazine 0.5 mg/day together with ketoconazole 400 mg/day led to an increase in total cariprazine AUC and Cmax of roughly 100% 1.
Common questions
Can I take Ribociclib and Cariprazine together?
Ribociclib can roughly double cariprazine levels by blocking its breakdown, so your care team will lower or space out your cariprazine dose and watch for side effects. Keep taking both as prescribed and confirm your dosing with your prescriber or pharmacist. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Ribociclib and Cariprazine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Ribociclib and Cariprazine interaction managed?
This combination is manageable with dose adjustment and monitoring. Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Your team will likely lower your cariprazine dose or space it further apart while you take ribociclib. For example, someone on a stable daily dose may be moved to a smaller dose taken every few days. They may watch you more closely for side… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Ribociclib or Cariprazine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
Keep reading about Ribociclib
Keep reading about Cariprazine
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist